Abstract
The thymus is a primary lymphoid organ that is essential for the establishment of adaptive immunity through generation of immunocompetent T cells. In response to various stress signals, the thymus undergoes acute but reversible involution. However, the mechanisms governing its recovery are incompletely understood. Here, we used a dexamethasone-induced acute thymic involution mouse model to investigate how thymic hematopoietic cells (excluding T cells) contribute to thymic regeneration. scRNA-seq analysis revealed marked transcriptional and cellular changes in various thymic populations and highlighted thymus-resident innate lymphoid cells type 2 (ILC2) as a key cell type involved in the response to damage. We identified that ILC2 are activated by the alarmins IL-25 and IL-33 produced in response to tissue damage by thymic tuft cells and fibroblasts, respectively. Moreover, using mouse models deficient in either tuft cells and/or IL-33, we found that these alarmins are required for effective thymus regeneration after dexamethasone-induced damage. We also demonstrate that upon their damage-dependent activation, thymic ILC2 produce several effector molecules linked to tissue regeneration, such as amphiregulin and IL-13, which in turn promote thymic epithelial cell differentiation. Collectively, our study elucidates a previously undescribed role for thymic tuft cells and fibroblasts in thymus regeneration through activation of the type 2 immune response.
Original language | English |
---|---|
Article number | eabq6930 |
Number of pages | 15 |
Journal | Science Immunology |
Volume | 9 |
Issue number | 91 |
DOIs | |
Publication status | Published - Jan 2024 |
Bibliographical note
We thank current and past members of the Abramson group for essential feedback and help. We also thank the personnel of the WIS animal facility for continuous support and M. Chemla from the WIS Genomics Unit for providing help and services regarding sequencing. We thank the NIH Tetramer Core Facility (contract number 75N93020D00005) for providing Brilliant Violet 421–conjugated CD1d-PBS57 and CD1d unloaded tetramers.Funding: Research in the Abramson laboratory is supported by the European Research Council (ERC-2016-CoG-724821), Bill and Marika Glied and Family Fund, Israel Science Foundation (1819/21), Binational Science Foundation (BSF), and Joseph and Sarah Bollag Fund; J.A. is an incumbent of the Eugene and Marcia Applebaum Professorial Chair and of the IOCB fellowship for sabbatical visit program (RVO 61388963).
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology